BDBM156366 US9018371, 6

SMILES: COc1ccc(Cl)cc1CNc1nc(Cl)nc2n(cnc12)[C@@H]1SCC(O)[C@@H]1O

InChI Key: InChIKey=LJLMHEFJMXWPHX-ALWGXXCGSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 156366   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Adenosine receptor A2a (Homo sapiens (Human))	BDBM156366 (US9018371, 6) Show SMILES COc1ccc(Cl)cc1CNc1nc(Cl)nc2n(cnc12)[C@@H]1SCC(O)[C@@H]1O |r| Show InChI InChI=1S/C17H17Cl2N5O3S/c1-27-11-3-2-9(18)4-8(11)5-20-14-12-15(23-17(19)22-14)24(7-21-12)16-13(26)10(25)6-28-16/h2-4,7,10,13,16,25-26H,5-6H2,1H3,(H,20,22,23)/t10?,13-,16+/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	12.7	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FM Therapeutics Co., Ltd.; The United States of America, As Represented by the Secretary, Department of Health and Human Services, The Office of Technology Transfer, National Institutes of Health US Patent					Assay Description CHO cells (ATCC No. CCL-61), in which A1 and A3 adenosine receptors were expressed, were cultured in F-12 media (Gibco, U.S.A.) supplemented with 10%...				US Patent US9018371 (2015) BindingDB Entry DOI: 10.7270/Q2G44P1K
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM156366 (US9018371, 6) Show SMILES COc1ccc(Cl)cc1CNc1nc(Cl)nc2n(cnc12)[C@@H]1SCC(O)[C@@H]1O |r| Show InChI InChI=1S/C17H17Cl2N5O3S/c1-27-11-3-2-9(18)4-8(11)5-20-14-12-15(23-17(19)22-14)24(7-21-12)16-13(26)10(25)6-28-16/h2-4,7,10,13,16,25-26H,5-6H2,1H3,(H,20,22,23)/t10?,13-,16+/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	4.02E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FM Therapeutics Co., Ltd.; The United States of America, As Represented by the Secretary, Department of Health and Human Services, The Office of Technology Transfer, National Institutes of Health US Patent					Assay Description CHO cells (ATCC No. CCL-61), in which A1 and A3 adenosine receptors were expressed, were cultured in F-12 media (Gibco, U.S.A.) supplemented with 10%...				US Patent US9018371 (2015) BindingDB Entry DOI: 10.7270/Q2G44P1K
					More data for this Ligand-Target Pair